Unilife Corporation (UNIS)
-NasdaqGM 3.81 
0.13(3.30%) 4:00PM EDT|After Hours
:
3.81 0.00 (0.00%) 4:31PM EDT
| Prev Close: | 3.94 |
|---|
| Open: | 3.95 |
|---|
| Bid: | 3.75 x 3100 |
|---|
| Ask: | 3.90 x 200 |
|---|
| 1y Target Est: | 6.35 |
|---|
| Beta: | 1.32 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 3.75 - 4.26 |
|---|
| 52wk Range: | 1.80 - 5.17 |
|---|
| Volume: | 1,990,106 |
|---|
| Avg Vol (3m): | 1,209,740 |
|---|
| Market Cap: | 321.51M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.73 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- UNILIFE CORP FinancialsEDGAR Online Financials(Fri, May 17)
- Taking a Closer Look at Medical Device and Product Companies, as Some are Generating High ROIs and Significant Free Cash Flow YieldsWall Street Transcript(Fri, May 17)
- [video] Deconstructing a Housing Stockat TheStreet(Wed, May 15)
- UNILIFE CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Tue, May 14)
- Today's Market News To Trade On: 5 Stocks Moving On Newsat Seeking Alpha(Tue, May 14)
- BRIEF-Unilife shares up 22.7 pct in premarket tradingat Reuters(Mon, May 13)
- UNILIFE CORP Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, May 13)
- [$$] Charting the Marketat Barrons.com(Sat, May 11)
- UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Fri, May 10)
- Unilife Management Discusses Q3 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 9)
- Unilife Corporation Announces Financial Results For Fiscal Year 2013 Third QuarterPR Newswire(Thu, May 9)
- Unilife: Here’s What Investors Need to Know Before Earningsat Wall St. Cheat Sheet(Thu, May 9)
- Q3 2013 Unilife Corp Earnings Release - After Market CloseCCBN(Thu, May 9)
- Looking For Opportunity - 5 Biotechs That Crashedat Seeking Alpha(Mon, May 6)
- UNILIFE CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Mon, Apr 29)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 100.69 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | -0.65 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.14 |
|---|
| Mean Recommendation*: | 1.2 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The companys principal product is the Unifill ready-to-fill syringe, which is designed for pha...
View More